Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2657 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Icon acquires Prevalere Life Sciences

Under the terms of the agreement Icon will pay initial cash consideration of $35 million. If certain performance milestones are achieved, a further consideration, up to a maximum

Valeant Pharmaceuticals acquires DermaTech

This transaction is said to expand Valeant’s Australian specialty pharmaceutical business through the acquisition of key products in both the retail and prescription brands, which complement Valeant’s current

Eisai wins FDA approval for seizure drug

Eisai has received a complete response letter for Banzel as an adjunctive treatment for partial-onset seizures with and without secondary generalization in adults and adolescents 12 years of

ADMETRx and Roche form collaboration

According to an ADMETRx release, ADMETRx and Roche both recognize how comprehensive data integration may offer significant advantages to discovery groups in selecting candidates for advancement. Phil Burton,

Zoll signs purchasing agreement with HealthTrust

Effective October 1, 2008, HealthTrust members are able to purchase medical devices from Zoll, initially including the R Series and M Series professional defibrillators, and the automated external